IEEE Spectrum on MSN1d
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...
The community is asked to support Cindy Walsh, a Danville woman who's been diagnosed with Amyotrophic Lateral Sclerosis, also ...
Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...
ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the ...
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
KALAMAZOO, Mich. — A charity hockey game is on the way to Western Michigan University's (WMU) Lawson Ice Arena this spring.
TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- The ALS Society of Canada (ALS Canada) was honoured to be selected to recognize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback